VariZIG for prophylaxis after exposure to varicella.
D002644:Chickenpox / Q000517:prevention & control*; D005260:Female; D014645:Herpesvirus 3, Human; D006801:Humans; D007106:Immune Sera / Q000008:administration & dosage* / Q000009:adverse effects; D007116:Immunization, Passive; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D017387:Investigational New Drug Application; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D007106:Immune Sera; C030799:varicella-zoster immune globulin